Ads
related to: Novavax and Vaccines
Search results
Novavax’s R&D head, integral to Covid vaccine work, to retire - Washington Business Journal
The Business Journals· 20 hours agoThe head of research and development at Novavax Inc., a key player in the development of its...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 1 week agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 2 weeks agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 2 weeks agoPer the terms, Sanofi will gain rights to co-market Nuvaxovid globally from next year, except in...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 1 week agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 6 days agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 2 weeks agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 1 week agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 2 weeks agoRival Moderna announced earlier this year that it would be pausing plans to build a plant in Kenya for vaccine development due to a drop in demand for...
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace via Yahoo Finance· 1 week agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
